BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34204007)

  • 1. Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics.
    Stiltner J; McCandless K; Zahid M
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade.
    Shoari A; Tooyserkani R; Tahmasebi M; Löwik DWPM
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.
    Bottens RA; Yamada T
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
    Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
    J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Targeting Peptide : From Identification to Validation to Mechanism of Transduction.
    Feldman KS; Pavlou MP; Zahid M
    Methods Mol Biol; 2021; 2211():97-112. PubMed ID: 33336273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery.
    Tian Y; Zhou S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1668. PubMed ID: 32929866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bio-Membrane Internalization Mechanisms of Arginine-Rich Cell-Penetrating Peptides in Various Species.
    Liu BR; Chiou SH; Huang YW; Lee HJ
    Membranes (Basel); 2022 Jan; 12(1):. PubMed ID: 35054614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility.
    Jones S; Lukanowska M; Suhorutsenko J; Oxenham S; Barratt C; Publicover S; Copolovici DM; Langel Ü; Howl J
    Hum Reprod; 2013 Jul; 28(7):1874-89. PubMed ID: 23585561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Penetrating Peptides as a Potential Drug Delivery System for Effective Treatment of Diabetes.
    Korivi M; Huang YW; Liu BR
    Curr Pharm Des; 2021; 27(6):816-825. PubMed ID: 33076803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac-Targeting Peptide: From Discovery to Applications.
    Sahagun D; Zahid M
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
    Zorko M; Jones S; Langel Ü
    Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy.
    Tripathi PP; Arami H; Banga I; Gupta J; Gandhi S
    Oncotarget; 2018 Dec; 9(98):37252-37267. PubMed ID: 30647857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides.
    Bolhassani A; Jafarzade BS; Mardani G
    Peptides; 2017 Jan; 87():50-63. PubMed ID: 27887988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New generation of cell-penetrating peptides: Functionality and potential clinical application.
    Reissmann S; Filatova MP
    J Pept Sci; 2021 May; 27(5):e3300. PubMed ID: 33615648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.